Black Friday Sale! Save huge on InvestingProGet up to 60% off

Takeda's dengue vaccine gets WHO endorsement, SomaLogic and Standard BioTools merge

EditorHari Govind
Published 10/04/2023, 10:34 PM
© Reuters.
IBB
-
XLV
-
TAK
-
SYBX
-
SLGC
-

In a series of recent developments in the biotechnology and healthcare sector, Takeda Pharmaceutical's dengue tetravalent vaccine Qdenga has received endorsement from the World Health Organization's advisory panel. The vaccine is set for deployment in high-risk areas among children aged six to 16 years. This news came on Wednesday, even as Takeda's shares slipped past 1%.

In other sector news, SomaLogic and Standard BioTools have announced an all-stock merger. The announcement of the merger propelled SomaLogic's shares 6% higher in premarket trading on Wednesday.

Meanwhile, Synlogic (NASDAQ:SYBX) has successfully closed its public offering, yielding approximately $21 million.

These events were reflected in minor oscillations in the iShares Biotechnology ETF and Health Care Select Sector SPDR Fund during premarket trading on Wednesday.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.